Answers are grounded in this paper and cite their sources.
Integrated single-cell transcriptomic analysis reveals immune microenvironment dynamics during metastasis in high-grade serous ovarian cancer, highlighting potential targets for novel therapies.
This study focuses on high-grade serous ovarian cancer (HGSOC), one of the most common histological subtypes of epithelial ovarian cancer worldwide, accounting for 75% of all ovarian cancer cases. The high mortality and poor prognosis of HGSOC are primarily attributed to its common intraperitoneal implantation metastasis, yet the precise mechanisms underlying this metastasis remain unknown. Here, we conducted a comprehensive integrated analysis of single-cell transcriptomic data in 21 primary and metastatic HGSOC samples from multiple public databases. Through integrating these data, we revealed the single-cell atlas of HGSOC in primary and metastatic tumors, providing insights into the dynamic changes in the tumor microenvironment during ovarian cancer metastasis. Furthermore, we explored key immune molecules associated with ovarian cancer metastasis. This study not only enhances our understanding of cellular heterogeneity and the dynamic changes in the tumor microenvironment during HGSOC metastasis, but also provides key clues for discovering novel therapeutic targets and developing more effective treatment strategies.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: